Macro

Meeting in emergency session in Vienna, the cartel capped total output at 18 million barrels a day, its first formal quota system. The producers' cartel had shifted from rationing scarce supply to defending prices against a glut, confirming the oil cycle had turned.

The energy sector is under clear pressure this month, with the world oil glut deepening and spot crude prices falling below OPEC’s $34 reference, signaling weak demand and oversupply. Despite this, sentiment holds neutral as broader macro conditions—though challenging—have not introduced additional shocks, leaving the sector in a state of strained equilibrium.

The Fortune 500 building-products maker sought bankruptcy protection citing 16,500 asbestos lawsuits and billions in projected claims. The unprecedented liability-driven filing established mass-tort risk as a first-order concern for industrial equity and bond investors.

Deep recession (10.8% unemployment) crushed the first half, but Volcker's July pivot and the August bull-market launch plus the Ford-UAW concession pact turned the mood decisively upward.

The deep recession bottomed with 10.8% unemployment, but the Fed's July pivot and the August bull-market launch on rate relief promised a consumer/auto recovery and lifted sentiment sharply into year-end.

The deep recession kept commodity prices and base-metals demand at cyclical lows through mid-year, but Volcker's July pivot to rate cuts lowered real rates and sparked a second-half gold and metals recovery.

Annual housing starts fell to roughly 1.08 million units, the weakest since demobilization, with sales of existing homes down by a third from 1978. The devastation in housing and related industries formed the core of the recession and the political backlash against the Fed.

Volcker's July pivot (discount rate cut to 11.5%) finally sent rates lower, sparking a bond rally and the start of housing's recovery; Garn-St Germain deregulation in October fed capital into property.

The FDIC closed the shopping-center bank that had originated and sold over $2 billion of reckless oil and gas participations to major banks. Uninsured depositors took losses for the first time in decades, and the fallout fatally wounded Seafirst and later Continental Illinois.

Financial sector sentiment is unexpectedly bullish despite pressure on banks to support Mexico’s liquidity needs, as the IMF’s public appeal signals confidence in the sector’s capacity to absorb the exposure. The positive read reflects relief that broader systemic risks were avoided, with markets interpreting the $5 billion call as a managed, coordinated intervention rather than a sign of distress.

AT&T has agreed to break up its Bell System by divesting 22 local operating companies within 18 months to settle a seven-year antitrust case. The Justice Department simultaneously dropped its long-running IBM antitrust suit, citing low chances of success. The moves signal a shift in antitrust policy and could reshape telecommunications and tech markets, with potential impacts on pricing and competition.

Recession deepens, ad market weak

WPPSS halted construction of units 4 and 5 amid cost overruns and collapsing demand forecasts. The termination set up the largest municipal bond default in history the following year and chilled financing for nuclear projects nationwide.

The utilities sector is trading bearish this month, weighed down by the high-profile termination of two nuclear plants by Washington Public Power, a move that casts doubt on the financial stability of similar bond-backed projects. With $2.25 billion in outstanding bonds now at risk, investor confidence in regulated utility credit quality has weakened. Broader energy reliability concerns and funding uncertainty amplify the caution, despite supportive macro tailwinds.

The FDA has approved Humulin, the first genetically engineered human insulin developed by Eli Lilly, Genentech, and City of Hope, marking a milestone in biotechnology. The synthetic insulin, produced using recombinant DNA technology, offers a safer, scalable alternative to animal-derived insulins with reduced risk of allergic reactions. This approval paves the way for expanded biotech drug development and could shift market preference toward human-identical insulin therapies.

After a grim recessionary start, Volcker's August pivot ignited a new bull market and October's FDA approval of Humulin, the first gene-spliced drug, turned healthcare sharply positive, validating my biotech bets.

Warner disclosed that Atari's video-game sales were collapsing, vaporizing roughly a third of the parent's market value overnight. The shock burst the home video-game bubble and previewed the industry-wide crash of 1983, a cautionary tale about hot consumer-tech earnings.

The tech sector is trading cautiously optimistic this month, supported by the resolution of two major regulatory overhangs. The DOJ’s decision to drop the IBM antitrust case and settle with AT&T has cleared near-term legal uncertainty, allowing investor focus to shift back to fundamentals and growth prospects. While broader macro conditions remain a backdrop, the removal of these specific headwinds has lifted sentiment modestly.

Double-digit real budget growth ran at full throttle; backlogs swelled across every prime with record peacetime procurement.